about
Effects of long-term feeding of the polyphenols resveratrol and kaempferol in obese miceModulation of mitochondrial Ca(2+) uptake by estrogen receptor agonists and antagonists.The plasma membrane Na+/Ca2+ exchange inhibitor KB-R7943 is also a potent inhibitor of the mitochondrial Ca2+ uniporter.Leptolide Improves Insulin Resistance in Diet-Induced Obese Mice.Nitric oxide decreases intestinal haemorrhagic lesions in rat anaphylaxis independently of mast cell activation.Ca2+ dynamics in the secretory vesicles of neurosecretory PC12 and INS1 cells.A confocal study on the visualization of chromaffin cell secretory vesicles with fluorescent targeted probes and acidic dyes.Modulation of histamine-induced Ca2+ release by protein kinase C. Effects on cytosolic and mitochondrial [Ca2+] peaks.Calcium dynamics in bovine adrenal medulla chromaffin cell secretory granules.Calcium dynamics in catecholamine-containing secretory vesicles.The dynamics of mitochondrial Ca2+ fluxes.Modulation of Ca(2+) release and Ca(2+) oscillations in HeLa cells and fibroblasts by mitochondrial Ca(2+) uniporter stimulationThe mitochondrial Na+/Ca2+ exchanger plays a key role in the control of cytosolic Ca2+ oscillationsLeiurus quinquestriatus venom inhibits different kinds of Ca2+-dependent K+ channelsCellular transport in the regulation of amino acid metabolismRegulation and genetics of amino acid transportGenetic studies of leucine transport in mammalian cellsDinucleosidetetraphosphatase from Ehrlich ascites tumour cells: inhibition by adenosine, guanosine and uridine 5'-tetraphosphates
P50
Q28544862-4B95560B-C15E-48F1-8BF8-5C4E8275DE41Q35049052-1049474C-6CC3-4372-8709-97687614AF29Q40217577-74E7ECE7-18AA-4855-BC45-DDC61110A44BQ41661857-F240C914-5CEB-4C48-9BD8-C9E425CA8E4DQ42435926-A846D7EB-592B-40F1-AAE7-8132C06C37C3Q42800047-019682E3-6006-4D21-B121-B7BA3CEA2D79Q42987300-D756EAEF-DA9A-42F2-9DDC-DD234BCBE513Q44605237-694B87A6-DCF9-46CB-80EE-CCB172DEC7C9Q46273330-D64F4B3E-FB81-45FB-ACDD-EE15C6728CD3Q46464274-73FBA3AE-7A1A-49E9-87DC-20FD109AFDA3Q46833465-CF10F2CB-F4B6-4085-899F-85CC9B144C51Q60395227-32C52A24-C7D4-4395-9E59-84D1599DDCC1Q60395230-B560E853-D94E-48A1-AAA8-C55F7DF3A5EEQ68957199-72ECEC78-654D-41F5-8552-E0DB754B9208Q69750003-8C6F51FE-2434-4CB4-BC8D-5067BA8FEDADQ69853724-00C135C7-925B-419B-B89E-F6A1C7F75E86Q71324670-56DA05F3-DDE7-4966-8424-57F158F58A30Q72940036-64C3C971-678E-413E-AF5C-D683BAE2B39E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alfredo Moreno
@ast
Alfredo Moreno
@en
Alfredo Moreno
@es
Alfredo Moreno
@nl
Alfredo Moreno
@pt
type
label
Alfredo Moreno
@ast
Alfredo Moreno
@en
Alfredo Moreno
@es
Alfredo Moreno
@nl
Alfredo Moreno
@pt
prefLabel
Alfredo Moreno
@ast
Alfredo Moreno
@en
Alfredo Moreno
@es
Alfredo Moreno
@nl
Alfredo Moreno
@pt
P106
P21
P31
P496
0000-0002-7444-5198